There's strong agreement across regulatory, law enforcement, and legislative perspectives that Congress will advance language allowing veterans to access psychedelic treatments — without rescheduling the drugs or changing how the FDA evaluates them for safety and effectiveness. This is a targeted workaround, not a broad legal change.
Consensus of 4 agents: fda_reviewer, legislator, dea_officer. 0 dissenting.